Stock Fundamentals

Company Information

▼
Company Name
PepGen Ltd
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US7133171055
CIK: 0001835597
CUSIP: 713317105
Currency: USD
Full Time Employees: 57
Phone: 781 797 0979
Website: https://pepgen.com
Fiscal Year End: December
IPO Date: May 06, 2022
Description:

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. Its lead product candidates comprise PGN-EDO51, an EDO peptide which is Phase 2 clinical trial to treat duchenne muscular dystrophy (DMD) patients that are amenable to an exon 51-skipping approach; PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and PGN-EDO53, which is in preclinical trial to treat duchenne muscular dystrophy. The company was founded in 2018 and is based in Boston, Massachusetts.

Address:

321 Harrison Avenue, Boston, MA, United States, 02118

Directors & Officers

▼
Name Title Year Born
Dr. James G. McArthur Ph.D. President, CEO, Treasurer, Secretary & Director 1962
Mr. Noel P. Donnelly M.B.A. Chief Financial Officer 1970
Dr. Paul D. Streck M.B.A., M.D. Executive VP and Head of Research & Development 1964
Dr. Michael Gait Ph.D. Founder & Scientific Advisory Board Member NA
Dr. Kasra Kasraian Ph.D. Chief Technology Officer NA
Ms. Emiko Bryant Senior Vice President of HR & Administration NA
Mr. Joseph D. Vittiglio Esq., J.D. Chief Business & Legal Officer 1972
Dr. Hayley Parker Ph.D. Senior Vice President of Global Regulatory Affairs & Quality NA

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
RA Capital Management, LLC 20.06M Dec 31, 2025 29.19% $1.34 0.00%
Viking Global Investors LP 3.48M Dec 31, 2025 5.07% $0.06 0.00%
COMMODORE CAPITAL LP 2.36M Sep 30, 2025 3.43% $0.53 0.00%
Vivo Capital, LLC 2.33M Dec 31, 2025 3.38% $0.98 0.00%
Vanguard Group Inc 2.21M Dec 31, 2025 3.22% $0.00 25.14%
Point72 Asset Management, L.P. 2.03M Sep 30, 2025 2.95% $0.02 -26.43%
Bvf Inc 1.92M Dec 31, 2025 2.79% $0.42 0.00%
LAURION CAPITAL MANAGEMENT LP 1.89M Sep 30, 2025 2.75% $0.15 133.38%
Nantahala Capital Management, LLC 1.55M Dec 31, 2025 2.25% $0.33 0.00%
HHG PLC 1.50M Sep 30, 2025 2.18% $0.00 0.00%
Pictet Asset Manangement SA 1.35M Dec 31, 2025 1.97% $0.01 180.96%
Woodline Partners LP 1.31M Dec 31, 2025 1.91% $0.03 0.00%
Awm Investment Company Inc 1.30M Dec 31, 2025 1.89% $0.82 26.83%
Deep Track Capital, LP 1.20M Sep 30, 2025 1.75% $0.15 0.00%
TCG Crossover Management, LLC 1.20M Sep 30, 2025 1.75% $0.27 0.00%
Balyasny Asset Management LLC 866.27K Dec 31, 2025 1.26% $0.01 -35.04%
Perceptive Advisors LLC 829.87K Sep 30, 2025 1.21% $0.11 0.00%
Logos Global Management LP 750.00K Sep 30, 2025 1.09% $0.31 0.00%
Siren, L.L.C. 700.00K Dec 31, 2025 1.02% $0.14 0.00%
Octagon Capital Advisors LP 700.00K Dec 31, 2025 1.02% $0.55 0.00%

Shares Statistics

▼
Shares Outstanding: 68.75M
Shares Float: 40.18M
% Insiders: 17.90%
% Institutions: 9,275.40%
Short % Float: 5.35%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 RA Capital Management, LLC 20.06M 29.19% ▲ 0.00% Dec 31, 2025
2 Viking Global Investors LP 3.48M 5.07% ▲ 0.00% Dec 31, 2025
3 COMMODORE CAPITAL LP 2.36M 3.43% ▲ 0.00% Sep 30, 2025
4 Vivo Capital, LLC 2.33M 3.38% ▲ 0.00% Dec 31, 2025
5 Vanguard Group Inc 2.21M 3.22% ▲ 25.14% Dec 31, 2025
6 Point72 Asset Management, L.P. 2.03M 2.95% ▼ 26.43% Sep 30, 2025
7 Bvf Inc 1.92M 2.79% ▲ 0.00% Dec 31, 2025
8 LAURION CAPITAL MANAGEMENT LP 1.89M 2.75% ▲ 133.38% Sep 30, 2025
9 Nantahala Capital Management, LLC 1.55M 2.25% ▲ 0.00% Dec 31, 2025
10 HHG PLC 1.50M 2.18% ▲ 0.00% Sep 30, 2025

Valuation Metrics

▼
Enterprise Value: $281.39M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $427.61M
EBITDA: $-96.81M
Book Value: $2.37
Earnings/Share: $-2.82
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -34.09%
ROE (TTM): -62.25%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 7.41x 0.03x 0.21x N/A -0.03x
2023-12-31 6.43x 0.03x 0.24x N/A -0.04x
2022-12-31 9.88x 0.03x 0.17x -20.11x -0.08x
2021-12-31 13.56x 0.00x 0.07x -157.61x 0.00x
2020-12-31 12.31x 0.00x 0.08x -234.63x 0.00x
2019-12-31 11.58x 0.00x 0.08x N/A 0.00x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 30, 2025 Science Enterprises Plc Oxford N/A Purchase 200.00K $3.20 $640.00K
May 30, 2025 Paul Streck N/A Purchase 8.38K $1.24 $10.39K
Apr 17, 2025 James G Mcarthur N/A Purchase 10.00K $1.35 $13.50K
Apr 08, 2025 James G Mcarthur N/A Purchase 41.50K $1.15 $47.73K
Feb 26, 2025 Mary Beth Delena N/A Sale 1.43K $1.68 $2.41K
Feb 26, 2025 Noel Donnelly N/A Sale 1.53K $1.68 $2.57K

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PEPG.US!